Shares of Zynex Plunge Over 80% in a Year, Hit New Lows Amid Mounting Challenges Zynex shares have tumbled to a 52-week low of $2.12, marking an 83% annual decline. The company reported a net loss in Q4, missed revenue forecasts, and faces Tricare payment suspensions. Despite strong gross margins, the company’s outlook remains bleak as it navigates ongoing legal and market headwinds.45